<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-5633</journal-id>
<journal-title><![CDATA[Revista Colombiana de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Colomb. Cardiol.]]></abbrev-journal-title>
<issn>0120-5633</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Colombiana de Cardiologia. Oficina de Publicaciones]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-56332024000100004</article-id>
<article-id pub-id-type="doi">10.24875/rccar.21000120</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Índice leucoglucémico como predictor de complicaciones en el infarto de miocardio: registro RECUIMA]]></article-title>
<article-title xml:lang="en"><![CDATA[Leuko-glycemic index as a predictor of complications in myocardial infarction: RECUIMA registry]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez-García]]></surname>
<given-names><![CDATA[Geovedy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez-Ramos]]></surname>
<given-names><![CDATA[Miguel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos-Medina]]></surname>
<given-names><![CDATA[Maikel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mata-Cueva]]></surname>
<given-names><![CDATA[Lázaro A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carrero-Vázquez]]></surname>
<given-names><![CDATA[Annia M.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chipi-Rodríguez]]></surname>
<given-names><![CDATA[Yanitsy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de La Habana Hospital General Docente &#8220;Enrique Cabrera&#8221; Servicio de Cardiología]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Ciencias Médicas de Sancti Hospital General Docente &#8220;Camilo Cienfuegos&#8221; Servicio de Cardiología]]></institution>
<addr-line><![CDATA[Las Tunas ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Ciencias Médicas de Las Tunas Hospital General Docente &#8220;Dr. Ernesto Guevara de la Serna&#8221; Servicio de Cardiología]]></institution>
<addr-line><![CDATA[Las Tunas ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Ciencias Médicas de Villa Clara Hospital General Docente &#8220;Mártires del 9 de abril&#8221; Servicio de Cardiología]]></institution>
<addr-line><![CDATA[Villa Clara ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2024</year>
</pub-date>
<volume>31</volume>
<numero>1</numero>
<fpage>4</fpage>
<lpage>11</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-56332024000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-56332024000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-56332024000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: La evaluación sinérgica de la hiperglucemia y el leucograma, como índice leucoglucémico (ILG), se asocia a un mayor número de eventos adversos durante el internamiento en pacientes con infarto agudo de miocardio con elevación del ST (IAMCEST).  Objetivo: Evaluar el valor predictivo del índice leucoglucémico (ILG) en la aparición de complicaciones intrahospitalarias en el infarto agudo de miocardio con elevación del segmento ST (IAMCEST).  Materiales y método: Estudio multicéntrico, observacional analítico, de cohorte histórica, que incluyó a 1.133 pacientes insertados en el Registro Cubano de Infarto del Miocardio Agudo entre enero de 2018 y junio de 2021. Los pacientes fueron divididos en cuartiles y en grupos de acuerdo con el punto de corte calculado para el ILG.  Resultados: El punto de corte óptimo del ILG para predecir complicaciones fue de 1188.4 (sensibilidad 61.4%; especificidad 57.3%; área bajo la curva 0.609; p &lt; 0.001). La aparición de complicaciones intrahospitalarias se incrementó de manera significativa en los cuartiles del ILG, así como en los dos grupos de acuerdo con el punto de corte. El análisis de regresión logística reveló que el ILG era un predictor independiente de complicaciones intrahospitalarias (OR [IC 95%] = 1.27 [1.11-1.46]; p = 0.001). Al asociar el ILG al modelo multivariado se elevó su capacidad predictiva (área bajo la curva 0.813; p &lt; 0.001). Las curvas de Kaplan-Meier mostraron diferencias significativas entre los grupos de pacientes (p = 0.030).  Conclusiones: El ILG constituye un predictor independiente de aparición de complicaciones intrahospitalarias en el IAMCEST. La adición del ILG a un modelo basal de riesgo tiene un fuerte efecto positivo en la predicción de pronósticos adversos en pacientes con diagnóstico de IAMCEST.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: The synergetic evaluation of the hyperglycemia and the white blood count as leukoglycemic index (LGI) joins a bigger number of adverse events during the internment in patients with ST Elevation Myocardial Infarction (STEMI).  Objective: To evaluate the predictive value of the leukoglycemic index (LGI) in the appearing of in-hospital complications in ST-elevation myocardial infarction (STEMI).  Method: Multicentral and historic cohort study, which included 1133 patients inserted in the Cuban Registry of Acute Myocardial Infarction, among January 2018 and June 2021. Patients were divided in quartiles and in groups according to the optimal cut-point calculated for the LGI.  Results: Optimal cut-point of the ILG to predict complications was 1188.4 (sensibility 61.4%; specificity 57.3%; area under curve 0.609; p &lt; 0.001). The appearing of in-hospital complications was significantly increased in the LGI’s quartiles; as well as in the two groups according to cut-point. The analysis of logistic regression revealed that the LGI was an independent predictor of in-hospital complications (OR [IC 95%] = 1.27 [1.11-1.46]; p = 0.001). When the LGI was associated to the multivariate model, its predictive capability was rose (area under curve 0.813; p &lt; 0.001). Kaplan Meier’s curves showed significant differences among groups of patient (p = 0.030).  Conclusions: The LGI is an independent predictor of appearing of in-hospital complications in STEMI. The addition of the LGI to a basal model of risk has a strong positive effect in the prediction of adverse prognosis in patients with STEMI.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Índice leucoglucémico]]></kwd>
<kwd lng="es"><![CDATA[Infarto agudo de miocardio]]></kwd>
<kwd lng="es"><![CDATA[Glucemia]]></kwd>
<kwd lng="es"><![CDATA[Leucocitos]]></kwd>
<kwd lng="en"><![CDATA[Leukoglycemic index]]></kwd>
<kwd lng="en"><![CDATA[Acute myocardial infarction]]></kwd>
<kwd lng="en"><![CDATA[Glycemia]]></kwd>
<kwd lng="en"><![CDATA[Leukocytes]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bajaj]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sethi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rathor]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Suppogu]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sethi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute complications of myocardial infarction in the current era:diagnosis and management]]></article-title>
<source><![CDATA[J Investig Med [Internet]]]></source>
<year>2015</year>
<volume>63</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>844-55</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schiele]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Gale]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Bonnefoy]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Capuano]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Claeys]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Danchin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality indicators for acute myocardial infarction:a position paper of the Acute Cardiovascular Care Association]]></article-title>
<source><![CDATA[Eur Heart J Acute Cardiovasc Care [Internet]]]></source>
<year>2017</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>34-59</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bebb]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fox]]></surname>
<given-names><![CDATA[KAA]]></given-names>
</name>
<name>
<surname><![CDATA[Dondo]]></surname>
<given-names><![CDATA[TB]]></given-names>
</name>
<name>
<surname><![CDATA[Timmis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bueno]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Performance of hospitals according to the ESC ACCA quality indicators and 30- day mortality for acute myocardial infarction:national cohort study using the United Kingdom Myocardial Ischemia National Audit Project (MINAP) register]]></article-title>
<source><![CDATA[Eur Heart J [Internet]]]></source>
<year>2017</year>
<volume>38</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>974-82</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<collab>Ministerio de Salud Pública Cuba</collab>
<article-title xml:lang=""><![CDATA[Dirección de registros médicos y estadísticas de salud]]></article-title>
<source><![CDATA[Anuario Estadístico de Salud 2020. La Habana, 2021]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[Sh]]></given-names>
</name>
<name>
<surname><![CDATA[Murugiah]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[Z-H]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Admission glucose and in-hospital mortality after acute myocardial infarction in patients with or without diabetes:a cross-sectional study]]></article-title>
<source><![CDATA[Chin Med J (Eng) [Internet]]]></source>
<year>2017</year>
<volume>130</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>767-75</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Barreiro]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[RQG]]></given-names>
</name>
<name>
<surname><![CDATA[Barreiro]]></surname>
<given-names><![CDATA[AEN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo de mortalidad hospitalaria post infarto agudo de miocardio]]></article-title>
<source><![CDATA[Rev Cub Cardiol Cirug Cardiovasc [Internet]]]></source>
<year>2017</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>27-44</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Issa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alqahtani]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Berzingi]]></surname>
<given-names><![CDATA[Ch]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Hajji]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Busu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Alkhouli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of acute diabetes decompensation on outcomes of diabetic patients admitted with ST-elevation myocardial infarction]]></article-title>
<source><![CDATA[Diabetol Metab Syndr [serie en Internet]]]></source>
<year>2018</year>
<volume>10</volume>
<page-range>57</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pesaro]]></surname>
<given-names><![CDATA[AEP]]></given-names>
</name>
<name>
<surname><![CDATA[Nicolau]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano Jr]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
<name>
<surname><![CDATA[Truffa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gaz]]></surname>
<given-names><![CDATA[MVB]]></given-names>
</name>
<name>
<surname><![CDATA[Karbstein]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influencia de leucocitos y glucemia en el pronóstico de pacientes con infarto agudo de miocardio]]></article-title>
<source><![CDATA[Arq Bras Cardiol [Internet]]]></source>
<year>2009</year>
<volume>92</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>84-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Akhtar]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Adil]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Habib-ur-Rehman]]></surname>
</name>
<name>
<surname><![CDATA[Shahs]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of leukocyte counts in patients with unstable angina pectoris or myocardial infarction:prognostic significance and correlation with plasma brain natriuretic peptide (BNP) levels]]></article-title>
<source><![CDATA[J Pak Med Assoc [Internet]]]></source>
<year>2011</year>
<volume>61</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>51-4</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guasti]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dentali]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Castiglioni]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Maroni]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Marino]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Squizzato]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularization. A systematic review on more than 34,000 subjects]]></article-title>
<source><![CDATA[Thromb Haemost [Internet]]]></source>
<year>2011</year>
<volume>106</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>591-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quiroga]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Conci]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Zelaya]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Isa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pacheco]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sala]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estratificación del riesgo en el infarto agudo de miocardio según el índice leucoglucémico. ¿El Killip-Kimball de laboratorio?]]></article-title>
<source><![CDATA[Rev Fed Arg Cardiol [Internet]]]></source>
<year>2010</year>
<volume>39</volume>
<page-range>29-34</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Prohias]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Mata]]></surname>
<given-names><![CDATA[LAC]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
<name>
<surname><![CDATA[Sellen]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Registro Cubano de Infarto de Miocardio Agudo (RECUIMA), los primeros 1000 casos]]></article-title>
<source><![CDATA[Rev Cub Cardiol Cir Cardiovasc [Internet]]]></source>
<year>2019</year>
<volume>25</volume>
<numero>3 Suppl 1</numero>
<issue>3 Suppl 1</issue>
<page-range>419-35</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Prohias]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa]]></surname>
<given-names><![CDATA[LAM]]></given-names>
</name>
<name>
<surname><![CDATA[Dueñas]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[De]]></surname>
<given-names><![CDATA[Lara JGA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bases metodológicas del registro cubano de infarto agudo del miocardio:de la utopía a la realidad]]></article-title>
<source><![CDATA[Rev Cub Cardiol Cir Cardiovasc [Internet]]]></source>
<year>2017</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>4-10</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thygesen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Alpert]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Jaffe]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Chaitman]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Bax]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[HD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio]]></article-title>
<source><![CDATA[Rev Esp Cardiol [Internet]]]></source>
<year>2019</year>
<volume>72</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>72.e1-e27</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Echeverría]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Chuquel]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lange]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Escalante]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Comisario]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Teoría Inflamatoria del SCA:índice leucoglucémico como factor pronóstico]]></article-title>
<source><![CDATA[Rev Conarec [Internet]]]></source>
<year>2012</year>
<volume>28</volume>
<numero>113</numero>
<issue>113</issue>
<page-range>31-5</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hirschson]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Higa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Merlo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Domine]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Blanco]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valor pronóstico del índice leucoglucémico en el infarto agudo de miocardio. Resultados del Registro Multicéntrico SCAR]]></article-title>
<source><![CDATA[Rev Argent Cardiol [Internet]]]></source>
<year>2014</year>
<volume>82</volume>
<page-range>500-5</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Índice leucoglucémico como predictor de complicaciones en el síndrome coronario agudo]]></article-title>
<source><![CDATA[Med Crit [Internet]]]></source>
<year>2018</year>
<volume>32</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>27-33</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[León-Aliz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno-Martínez]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Fernández]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Vega-Fleites]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Rabassa-López-Calleja]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Índice leucoglucémico como marcador pronóstico de la evolución intrahospitalaria en pacientes con infarto agudo de miocardio con elevación del ST]]></article-title>
<source><![CDATA[Clin Invest Arterioscl [Internet]]]></source>
<year>2014</year>
<volume>26</volume>
<page-range>167-74</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[REB]]></given-names>
</name>
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[AMM]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[LMH]]></given-names>
</name>
<name>
<surname><![CDATA[Carvajal]]></surname>
<given-names><![CDATA[PAS]]></given-names>
</name>
<name>
<surname><![CDATA[Coronado]]></surname>
<given-names><![CDATA[YH]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[EMR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hemoglobina glucosilada e índice leucoglucémico como determinaciones pronósticas en el síndrome coronario agudo]]></article-title>
<source><![CDATA[CorSalud [Internet]]]></source>
<year>2016</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>153-63</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Padilla-Cueto]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Negrín]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Gómez]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Valdivia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cárdenas-Sánchez]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Alfonso-Izquierdo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El índice leucoglucémico es un predictor de mortalidad por todas las causas al año en pacientes cubanos con infarto agudo de miocardio con elevación del segmento ST]]></article-title>
<source><![CDATA[CorSalud [Internet]]]></source>
<year>2019</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Jiménez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fardales-Rodríguez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Toledo-Rodríguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Quintana-Cañizarez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Índice leucoglucémico como factor pronóstico tras un infarto agudo del miocardio con elevación del segmento ST]]></article-title>
<source><![CDATA[Rev Finlay [Internet]]]></source>
<year>2019</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
